Ultrasound Attenuation Imaging Tracks Hepatic Steatosis

Attenuation imaging increased with visually graded steatosis severity in pediatric patients, but findings were not validated against MRI-PDFF or biopsy.

By
Kathryn Wighton
May 11, 2026
4 min

Conexiant

At a Glance

Category	Detail
Condition	Hepatic Steatosis in Pediatric Patients
Key Mechanisms	Ultrasound-based attenuation imaging values reflect hepatic fat-related acoustic attenuation.
Target Population	Children with overweight or obesity
Care Setting	Single-center, pediatric hospital

Key Highlights

Increased attenuation imaging values correlate with steatosis severity.
Median values: 0.51 dB/cm/MHz (healthy), 0.54 (overweight), 0.64 (obesity).
Strong association between attenuation values and steatosis grade (η² = 0.626).
No significant correlation with sex; strongest correlation with alanine aminotransferase.
Study limitations include lack of MRI-PDFF validation and single-center design.

Guideline-Based Recommendations

Diagnosis

Use ultrasound attenuation imaging to assess hepatic steatosis severity.

Management

Consider metabolic and anthropometric measures alongside imaging results.

Monitoring & Follow-up

Regularly monitor liver function tests, including alanine aminotransferase.

Risks

Caution against broad generalization of results due to single-center study limitations.

Patient & Prescribing Data

Children with overweight or obesity, aged 2-18 years.

Further multicenter studies needed to validate findings and establish clinical utility.

Clinical Best Practices

Incorporate standardized protocols for attenuation imaging across different ultrasound platforms.
Consider histologic validation in selected patients for accurate diagnosis.